| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |